FinTechFunding

Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Previous article
MRG Metals: Completes phase two drilling in Mozambique
Next article
PainChek: Signs partnership deal with disability service provider
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Regulators Strengthen Global Crackdown on Finfluencers

A new collaborative approach targets financial influencers amid rising concerns.Highlights: Financial regulators unite to control finfluencers' market impact.Concerns...
FinTech

ECB Strengthens Digital Euro Rollout with Standard Setter Agreements

New collaborations aim to facilitate the digital euro's global integration.Highlights: ECB partners with key global standard setters.Agreements aim...
FinTech

CreditNature Strengthens Nature Restoration Funding Through Everyday Transactions

New partnership enables businesses to support environmental initiatives seamlessly.Highlights: CreditNature teams up with Stabiliti for eco-friendly funding.Businesses can...
FinTech

FedNow Strengthens Instant Payments Security with New API Tool

New API tool enhances security for immediate digital transactions in the U.S.Highlights: FedNow introduces a new API tool...